« Previous
Next »
Titles
- BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment1
- Benefit-risk assessment for new drug and biological products: guidance for industry1
- Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice1
- Best practices for convening a GRAS panel: guidance for industry1
- Bioanalytical method validation1
- Brain injury rehabilitation in adults: a national clinical guideline1
- Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff1
- British guideline on the management of asthma: a national clinical guideline1